Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Related Articles by Review for PubMed (Select 16354907)

1.

IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

Deane R, Sagare A, Hamm K, Parisi M, LaRue B, Guo H, Wu Z, Holtzman DM, Zlokovic BV.

J Neurosci. 2005 Dec 14;25(50):11495-503.

2.

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Deane R, Bell RD, Sagare A, Zlokovic BV.

CNS Neurol Disord Drug Targets. 2009 Mar;8(1):16-30. Review.

3.

Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.

Wang YJ, Zhou HD, Zhou XF.

Drug Discov Today. 2006 Oct;11(19-20):931-8. Epub 2006 Sep 7. Review.

PMID:
16997144
4.

Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy.

Nitsch RM, Hock C.

Neurotherapeutics. 2008 Jul;5(3):415-20. doi: 10.1016/j.nurt.2008.05.013. Review.

PMID:
18625453
5.

Antibody-mediated immunotherapy for Alzheimer's disease.

Solomon B.

Curr Opin Investig Drugs. 2007 Jul;8(7):519-24. Review.

PMID:
17659471
6.

Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Deane R, Zlokovic BV.

Curr Alzheimer Res. 2007 Apr;4(2):191-7. Review.

PMID:
17430246
7.

Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.

Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN.

Mol Psychiatry. 2009 May;14(5):469-86. doi: 10.1038/mp.2008.96. Epub 2008 Sep 16. Review. Erratum in: Mol Psychiatry. 2009 Dec;14(12):1144.

PMID:
18794889
8.

Lipid metabolism, epidemiology, and the mechanisms of Alzheimer's disease.

Friedland RP.

Ann N Y Acad Sci. 2002 Nov;977:387-90. Review.

PMID:
12480777
9.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
10.

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

Tanzi RE, Moir RD, Wagner SL.

Neuron. 2004 Sep 2;43(5):605-8. Review.

11.

Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.

Donahue JE, Johanson CE.

J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70. doi: 10.1097/NEN.0b013e31816a0dc8. Review. Erratum in: J Neuropathol Exp Neurol. 2008 Jun;67(6):634.

PMID:
18379441
12.

Transporters in the brain endothelial barrier.

Ueno M, Nakagawa T, Wu B, Onodera M, Huang CL, Kusaka T, Araki N, Sakamoto H.

Curr Med Chem. 2010;17(12):1125-38. Review.

PMID:
20175745
14.

Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.

Pflanzner T, Kuhlmann CR, Pietrzik CU.

Curr Alzheimer Res. 2010 Nov;7(7):578-90. Review.

PMID:
20704558
15.

Amyloid-beta immunotherapies in mice and men.

Brendza RP, Holtzman DM.

Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):118-23. Review.

PMID:
16772748
16.

LRP in amyloid-beta production and metabolism.

Bu G, Cam J, Zerbinatti C.

Ann N Y Acad Sci. 2006 Nov;1086:35-53. Review.

PMID:
17185504
17.

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Mamo JC.

Prog Lipid Res. 2010 Apr;49(2):159-70. doi: 10.1016/j.plipres.2009.10.004. Epub 2009 Nov 5. Review.

PMID:
19896503
18.

Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

Cerpa W, Dinamarca MC, Inestrosa NC.

Curr Alzheimer Res. 2008 Jun;5(3):233-43. Review.

PMID:
18537540
19.

Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.

Alvira-Botero X, Carro EM.

Curr Aging Sci. 2010 Dec;3(3):219-29. Review.

PMID:
20735345
20.

Mechanisms of Abeta clearance and catabolism.

Guénette SY.

Neuromolecular Med. 2003;4(3):147-60. Review.

PMID:
14716023
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk